Stocktoria
Intellia Therapeutics, Inc. NTLA
Nasdaq · XNAS · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 2016-05-06
Intellia Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 9,597,607 | $214.8M |
| ARK Investment Management LLC | 14,509,247 | $186.0M |
| D. E. Shaw & Co., Inc. | 5,728,177 | $73.4M |
| TWO SIGMA INVESTMENTS, LP | 4,705,901 | $60.3M |
| CITADEL ADVISORS LLC | 1,117,641 | $14.3M |
| AQR CAPITAL MANAGEMENT LLC | 630,529 | $8.1M |
| Point72 Asset Management, L.P. | 297,011 | $3.8M |
| MILLENNIUM MANAGEMENT LLC | 70,559 | $904,566 |
Source: SEC EDGAR filings · CIK 0001652130 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.